latest blog entries
Loading...
Branding...
latest headlines for company on cafepharma
The Medical News
Sat, 04/17/10 - 12:49 pm
Forbes/Reuters
Wed, 08/19/09 - 7:29 am
tags: anti-fungal, BioAlliance, FDA, Loramyc, Par Pharmaceutical, Strativa
Last 30 twitter posts
-
RT @FranceBiotech: Accord pour l'admission des actions d'#Onxeo - Echange des actions émises le 5 août 2014 - t.co/hwMqhywSEm
-
Accord pour l'admission des actions d'#Onxeo - Echange des actions émises le 5 août 2014 - t.co/hwMqhywSEm
-
BioAlliance/Topotarget merged firm to list in Copenhagen in August t.co/k9wRA0zjMi
-
News: BioAlliance Pharma Approval of Onxeos admission to secondary listing and trading on NASDAQ OMX Copenhage... t.co/l3l8Moj4Kz
-
Dental Practice News BioAlliance/Topotarget merged firm to list in Copenhagen in August t.co/yaGtgsZa6N t.co/GDZ5AQRikL
-
BioAllianceTopotarget merged firm to list in Copenhagen in August t.co/e8MuLUQoQp
-
BioAlliance Pharma Approval of Onxeos admission to secondary listing and trading on NASDAQ OMX Copenhagen t.co/iDzrVrMDXk
-
News: #medicine BioAlliance Pharma Approval of Onxeos admission to secondary listing and trading on NASDAQ OMX Cop... t.co/nqsFVXSGaK
-
BioAlliance Pharma Approval of Onxeos admission to secondary listing and trading on NASDAQ OMX Copenhagen t.co/w6BNrcDG7X
-
BIOALLIANCE-PHARMA: BioAlliance Pharma: Approval of Onxeo’s admission to secondary listing and trading on NASD... t.co/JbRKjhD4Xb
-
BioAlliance Pharma Approval of Onxeos admission to secondary listing and trading on NASDAQ OMX Copenhagen t.co/cyikhhOuN6
-
News: BioAlliance Pharma Approval of Onxeos admission to secondary listing and trading on NASDAQ OMX Copenhagen t.co/mNOONOEB6C
-
BioAlliance Pharma : Fusion autorisée avec Topotarget t.co/v6Itoec3bk
-
BioAlliance Pharma : Fusion autorisée avec Topotarget t.co/EutWMBTMov
-
BioAlliance Pharma: Approval of Onxeo’s admission to secondary listing and trading on NASDAQ OMX Copenhagen t.co/sRMnbZZqub
-
BioAlliance Pharma: Approval of Onxeo’s admission to secondary listing and trading on NASDAQ OMX Copenhagen t.co/Q4JjXCdv2P
-
Fusion de BioAlliance Pharma avec Topotarget t.co/RLknhLNt1R
-
BioAlliance/Topotarget merged firm to list in Copenhagen in August t.co/OyXtjUSq7q
-
BioAlliance Pharma: Approval of Onxeo’s admission to secondary listing and trading on NASDAQ OMX Copenhagen t.co/7gShXYj5Kq
-
Fusion de BioAlliance Pharma avec Topotarget t.co/TR1e2F17cA
-
BioAlliance/Topotarget merged firm to list in Copenhagen in August t.co/Nnz364Jozd #Healthcare
-
BioAlliance/Topotarget merged firm to list in Copenhagen in August #news
-
BIOALLIANCE PHARMA : Fusion de BioAlliance Pharma avec Topotarget t.co/b6pNay3wMs
-
$BIO - Fusion de BioAlliance Pharma avec Topotarget t.co/RshnDMmGQ2
-
$BIO - BioAlliance Pharma: Approval of Onxeo’s admission to secondary listing and trading on NASDAQ OMX t.co/flwACrbtfp
-
BioAlliance Pharma: Approval of Onxeo’s admission to secondary listing and trading on NASDAQ OMX Copenhagen t.co/EiLT6i5Ivr
-
RT @EdisonHealth: Imminent #BioAlliance/#Topotarget #merger to create #Onxeo, with focus on orphan #oncology. $BIO val. ↑ to €187m t…
-
#Onxeo - Fusion transfrontalière de BioAlliance Pharma et Topotarget-t.co/xi6MOEprxW
-
BIOALLIAN.PHARMA. : Domdomdo perd -9.69% t.co/FnwQbPLslV
-
BioAlliance Pharma : fusion effective avec Topotarget le 22 juillet
